FibroGen

+$0.26 (+2.45%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer.

CEO
Enrique A. Conterno
Employees
599
Headquarters
San Francisco, California
Founded
1993

FGEN Key Statistics

Market Cap
1.01B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.05M
High Today
$10.88
Low Today
$10.29
Open Price
$10.46
Volume
1.14M
52 Week High
$57.21
52 Week Low
$9.88

FGEN News

Simply Wall StOct 17

Investors in FibroGen from three years ago are still down 79%, even after 5.9% gain this past week

As an investor, mistakes are inevitable. But you have a problem if you face massive losses more than once in a while. So consider, for a moment, the misfortune

FGEN Earnings

-$1.45
-$0.85
-$0.25
$0.35
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure